Market closed

Boston Scientific/$BSX

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Boston Scientific

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Ticker

$BSX

Sector

Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Headquarters

Marlborough, United States

Employees

48,000

Website

www.bostonscientific.com

BSX Metrics

BasicAdvanced

$139B

78.26 $1.21

0.80 -

Price and volume

Market cap

$139B

Beta

0.8

52-week high

$97.13

52-week low

$59.61

Average daily volume

4.6M

Financial strength

Current ratio

1.482

Quick ratio

0.847

Long term debt to equity

45.839

Total debt to equity

53.064

Interest coverage (TTM)

9.76%

Management effectiveness

Return on assets (TTM)

4.90%

Return on equity (TTM)

8.92%

Valuation

Price to earnings (TTM)

78.259

Price to revenue (TTM)

8.737

Price to book

6.83

Price to tangible book (TTM)

255.84

Price to free cash flow (TTM)

63.798

Growth

Revenue change (TTM)

15.66%

Earnings per share change (TTM)

47.19%

3-year revenue growth (CAGR)

11.53%

3-year earnings per share growth (CAGR)

16.30%

What the Analysts think about BSX

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Boston Scientific stock.

BSX Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

BSX Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

BSX News

AllArticlesVideos

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

CNBC Television·4 days ago

Final Trades: Apollo, UnitedHealth, Boston Scientific and the IYF

CNBC Television·6 days ago

Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal

Benzinga·7 days ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BSX

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Boston Scientific stock?

Boston Scientific (BSX) has a market cap of $139B as of January 15, 2025.

What is the P/E ratio for Boston Scientific stock?

The price to earnings (P/E) ratio for Boston Scientific (BSX) stock is 78.26 as of January 15, 2025.

Does Boston Scientific stock pay dividends?

No, Boston Scientific (BSX) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Boston Scientific dividend payment date?

Boston Scientific (BSX) stock does not pay dividends to its shareholders.

What is the beta indicator for Boston Scientific?

Boston Scientific (BSX) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.